e-learning
resources
London 2016
Monday, 05.09.2016
Surgical strategy for complex diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The efficiency of surgical treatment for multidrug-resistant pulmonary and pleural tuberculosis
Azamat Sharipov (Tashkent, Uzbekistan), Azamat Sharipov, Mirzagaleb Tillyashaykhov, Odiljon Nematov, Shokirjon Mayusupov, Anvar Riskiev, Nematilla Toshev, Giller Dmitrii, Konstantin Valatin
Source:
International Congress 2016 – Surgical strategy for complex diseases
Session:
Surgical strategy for complex diseases
Session type:
Thematic Poster
Number:
2511
Disease area:
Respiratory infections, Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Azamat Sharipov (Tashkent, Uzbekistan), Azamat Sharipov, Mirzagaleb Tillyashaykhov, Odiljon Nematov, Shokirjon Mayusupov, Anvar Riskiev, Nematilla Toshev, Giller Dmitrii, Konstantin Valatin. The efficiency of surgical treatment for multidrug-resistant pulmonary and pleural tuberculosis. Eur Respir J 2016; 48: Suppl. 60, 2511
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
MOTT as a cause of treatment failure in pulmonary tuberculosis
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013
Combined collapse therapy in the treatment of cavitary pulmonary tuberculosis (CPTB)
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015
Side effects of chemical preparations in patients with drug-resistant pulmonary tuberculosis
Source: International Congress 2015 – Healthcare organisation and appropriateness in lung disorders
Year: 2015
Valvular bronchial blocking in the treatment of cavitary pulmonary tuberculosis (CPTB)
Source: International Congress 2016 – Bronchoscopy: from diagnostic to treating air leaks
Year: 2016
Collapse therapy using endobronchial valves as a new approach to treat cavities in MDR tuberculosis and selected cases of mycobacteriosis: Case series report
Source: International Congress 2015 – Advances in therapeutic bronchoscopy
Year: 2015
Consecutive surgical treatment for bilateral fibro-cavernous pulmonary TB
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
Endobronchial valve in complex treatment of patients with destructive pulmonary TB/HIV co-infection
Source: International Congress 2016 – Bronchoscopy: from diagnostic to treating air leaks
Year: 2016
Surgical approach to multidrug-resistant pulmonary tuberculosis
Source: Eur Respir J 2003; 22: Suppl. 45, 323s
Year: 2003
Frequency of rifampicin resistance in re-treatment cases of pulmonary tuberculosis using Gene-Xpert in a tertiary care hospital tuberculosis clinic
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
Management of multidrug-resistant tuberculosis and patients in retreatment
Source: Eur Respir J 2005; 25: 928-936
Year: 2005
Nonspecific microflora in patients associated with pulmonary multidrug-resistant tuberculosis
Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology
Year: 2015
Surgical treatment of multidrug resistant pulmonary tuberculosis (MDR-TB)
Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance
Year: 2009
Surgical treatment of multidrug-resistant tuberculosis (MDR TB)
Source: Eur Respir J 2003; 22: Suppl. 45, 523s
Year: 2003
Surgical complications of destructive pulmonary tuberculosis and ways of their correction
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
Treatment outcomes among multidrug-resistant tuberculosis (MDR-TB) cases at a referral hospital of infectious diseases in Italy
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
Management and treatment of multidrug-resistant tuberculosis
Source: International Congress 2019 – Tuberculosis: latest advances and challenges in patient management
Year: 2019
The MTBDRplus 2.0 for rapid diagnosis of multidrug-resistant tuberculosis among patients with high risk of TB resistance
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
Collapse therapy in cavitary pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Value of surgery for multidrug-resistant pulmonary tuberculosis in Hungary
Source: Eur Respir J 2006; 28: Suppl. 50, 135s
Year: 2006
Linezolid in the treatment of patients with MDR TB and XDR TB
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept